GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM
AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss Tags hBA1c GLP-1 agonists Read more about AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss
AACE 2026: GLP-1RAs Show Lower Rates of T1DM Complications Tags Diabetic Neuropathy Diabetic Nephropathy Retinopathy Coronary artery disease GLP-1 agonists Read more about AACE 2026: GLP-1RAs Show Lower Rates of T1DM Complications
Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis Tags GLP-1 agonists Read more about Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis
Best Drug for GDM? Outcomes Differ Across Classes Tags Sulphonylureas GLP-1 agonists Biguanide SGLT-2 Inhibitor Read more about Best Drug for GDM? Outcomes Differ Across Classes
Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM Tags hBA1c Sulphonylureas DPP-4 inhibitors Biguanide Read more about Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM
GLP-1 Therapies Show GI Effects but Preserve Lean Mass Tags GLP-1 agonists Read more about GLP-1 Therapies Show GI Effects but Preserve Lean Mass
GLP-1RAs Linked to Lower MACE Risk in Dialysis With T2DM Tags Coronary artery disease GLP-1 agonists DPP-4 inhibitors Read more about GLP-1RAs Linked to Lower MACE Risk in Dialysis With T2DM